Fei Cao

Francis Cao has served as our COO since 2018. Mr. Cao has over 15-year experience of operations, business development and management in biotech and pharmaceutical industry. From 2015 to 2018, Mr. Cao was Co-founder and CEO of Corestone Biosciences, Beijing. Prior to co-founding Corestone Bio, Mr. Cao held the Senior Director and also a Member of Corporate Management Committee position of BeiGene (NASDAQ: BGNE), a leading biopharmaceutical company in China. Prior to joining BeiGene, he held various managerial positions of business development, external scientific affairs, and investment in CapitalBio, GSK, and Johnson & Johnson. He received B.S. degree from Peking University in Biology and dual major in Economics. He enrolled in the PhD program at Department of Biology of Hong Kong University of Science and Technology and went to University of Pennsylvania School of Medicine as Visiting Scholar in 2003 and 2004.

Francis Cao has served as our COO since 2018. Mr. Cao has over 15-year experience of operations, business development and management in the biotech and pharmaceutical industry. From 2015 to 2018, Mr. Cao was Co-founder and CEO of Corestone Biosciences, Beijing. Prior to co-founding Corestone Bio, Mr. Cao held the Senior Director and also a Member of the Corporate Management Committee position of BeiGene (NASDAQ: BGNE), a leading biopharmaceutical company in China. Prior to joining BeiGene, he held various managerial positions in business development, external scientific affairs, and investment in CapitalBio, GSK, and Johnson & Johnson. He received a B.S. degree from Peking University in Biology and a dual major in Economics. He enrolled in the Ph.D. program at the Department of Biology of Hong Kong University of Science and Technology and went to University of Pennsylvania School of Medicine as a Visiting Scholar in 2003 and 2004.